Zyversa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression From Obesity to Insulin Resistance and Type 2 Diabetes
Zyversa Therapeutics突出發表的數據顯示，抑制炎症小體有潛力保護胰島β細胞，並減輕從肥胖到胰島素抵抗和2型糖尿病的發展
